Skip to main content
Explore our brands An Informa TechTarget Publication
close search
site logo

FDA warns of SGLT2 inhibitor-ketoacidosis link

Published May 17, 2015

Recommended Reading

Editors' picks

  • A stylized illustration of a "patent thicket" for Jonathan Gardner's Nov. 1 story on Amgen's Enbrel.
    Image attribution tooltip
    Adeline Kon / BioPharma Dive/BioPharma Dive
    Image attribution tooltip
    Deep Dive // Patent thickets

    Drug patents protect pharma profits. Track when they’ll expire.

    AbbVie reached legal settlements delaying the arrival of generic versions of Rinvoq until 2037, enabling four more years of exclusivity for a drug that banked about $6 billion in sales in 2024.

    By Jonathan Gardner • Updated April 9, 2025
  • A technician wearing a blue mask works in a laboratory.
    Image attribution tooltip
    Kevin Frayer via Getty Images
    Image attribution tooltip
    China competition

    Drugs from China are reshaping biotech. Track the licensing deals here.

    AstraZeneca, Pfizer and Bristol Myers Squibb have each allocated more than $16 billion to collaborations with Chinese drugmakers since the start of 2025 — surpassing all of their pharmaceutical peers over that timeframe.

    By Ben Fidler • Updated June 1, 2026

Company Announcements

View all | Post a press release
Baptist Health South Florida and The START Center for Cancer Research Announce Strategic Partn…
From The START Center for Cancer Research
May 28, 2026
The START Center for Cancer Research logo
Acuity Process Solutions and Eberbach Corporation Announce Strategic Partnership
From Acuity Process Solutions
May 27, 2026
Acuity Process Solutions logo
ProPharma Appoints Adrian Pencak as Chief Commercial Officer
From ProPharma
May 27, 2026
ProPharma logo
Almac Group delivers record year of growth
From Almac Group
May 20, 2026
Almac Group logo
Editors' picks
  • A stylized illustration of a "patent thicket" for Jonathan Gardner's Nov. 1 story on Amgen's Enbrel.
    Image attribution tooltip
    Adeline Kon / BioPharma Dive/BioPharma Dive
    Image attribution tooltip
    Deep Dive // Patent thickets

    Drug patents protect pharma profits. Track when they’ll expire.

    AbbVie reached legal settlements delaying the arrival of generic versions of Rinvoq until 2037, enabling four more years of exclusivity for a drug that banked about $6 billion in sales in 2024.

    By Jonathan Gardner • Updated April 9, 2025
  • A technician wearing a blue mask works in a laboratory.
    Image attribution tooltip
    Kevin Frayer via Getty Images
    Image attribution tooltip
    China competition

    Drugs from China are reshaping biotech. Track the licensing deals here.

    AstraZeneca, Pfizer and Bristol Myers Squibb have each allocated more than $16 billion to collaborations with Chinese drugmakers since the start of 2025 — surpassing all of their pharmaceutical peers over that timeframe.

    By Ben Fidler • Updated June 1, 2026
This website is owned and operated by Informa TechTarget, a global network that informs, influences and connects the world's technology buyers and sellers.

© 2025 TechTarget, Inc. or its subsidiaries. All rights reserved. An Informa PLC company.
Privacy policy | Terms of use | Take down policy | Cookie Preferences / Do Not Sell